Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses

Area of Science:

• Psychiatry
• Clinical Psychology
• Neuroscience

Background:

• Social anxiety disorder (SAD) is a prevalent mental health condition characterized by intense fear of social situations.
• Current treatment options for SAD include pharmacotherapy and psychotherapy, with varying degrees of effectiveness.
• Cognitive behavioral therapy (CBT) is a well-established psychotherapeutic approach that targets maladaptive thoughts and behaviors.

Purpose of the Study:

• To evaluate the effectiveness of CBT in reducing symptoms of social anxiety disorder.
• To assess the impact of CBT on social functioning and quality of life in patients with SAD.
• To compare the efficacy of CBT with other established treatments for SAD.

Main Methods:

• A randomized controlled trial (RCT) design was employed.
• Participants diagnosed with SAD were randomly assigned to either a CBT group or a control group.
• Symptom severity was assessed using standardized measures, such as the Liebowitz Social Anxiety Scale (LSAS).
• Functional outcomes were evaluated through self-report questionnaires and clinician ratings.

Main Results:

• The CBT group demonstrated a statistically significant reduction in social anxiety symptoms compared to the control group.
• Improvements in social functioning and quality of life were observed in patients receiving CBT.
• No significant differences were found when comparing CBT to other active treatments, suggesting comparable efficacy.

Conclusions:

• Cognitive behavioral therapy is an effective treatment for social anxiety disorder, leading to significant symptom reduction and functional improvement.
• CBT offers a valuable therapeutic option for individuals suffering from SAD.
• Further research is warranted to explore long-term outcomes and potential moderators of treatment response.